Frank Frissora

1.2k total citations
16 papers, 267 citations indexed

About

Frank Frissora is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Frank Frissora has authored 16 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Frank Frissora's work include Chronic Lymphocytic Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and T-cell and B-cell Immunology (3 papers). Frank Frissora is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and T-cell and B-cell Immunology (3 papers). Frank Frissora collaborates with scholars based in United States, China and Poland. Frank Frissora's co-authors include Natarajan Muthusamy, John C. Byrd, Qing Liu, David Jarjoura, Amy Lehman, Ching‐Shih Chen, Danilo Perrotti, Yihui Ma, James T. Dalton and Xiaobin Zhao and has published in prestigious journals such as Blood, Cancer Research and European Journal of Immunology.

In The Last Decade

Frank Frissora

16 papers receiving 264 citations

Peers

Frank Frissora

IMMUN

GENET

ONCOL

PFM

Benjamin T. Goetz United States

Sebastian W. Hofbauer Austria

Derek Bouman Canada

Michaël H. Meel Netherlands

Charis A. Venditti United States

Holly Yin United States

Federica Barbaglio Italy

Vladimir Janković United States

John F. Schwerkoske United States

Ildiko Grandal Canada

Benjamin T. Goetz United States

Frank Frissora

184 ×1.0

60 ×0.8

IMMUN

45 ×0.8

GENET

73 ×1.5

ONCOL

14 ×0.3

PFM

Citations per year, relative to Frank Frissora Frank Frissora (= 1×) peers Benjamin T. Goetz

Countries citing papers authored by Frank Frissora

Since Specialization

Citations

This map shows the geographic impact of Frank Frissora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Frissora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Frissora more than expected).

Fields of papers citing papers by Frank Frissora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Frissora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Frissora. The network helps show where Frank Frissora may publish in the future.

Co-authorship network of co-authors of Frank Frissora

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Frissora. A scholar is included among the top collaborators of Frank Frissora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Frissora. Frank Frissora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Chiang, Chi‐Ling, Frank Frissora, Zhiliang Xie, et al.. (2019). ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model. Blood. 134(5). 432–444. 33 indexed citations

Hu, Eileen, Priscilla Do, Rajeswaran Mani, et al.. (2019). Abstract 1541: Evaluation of ROR1 targeted antibody drug conjugate in ROR1 positive leukemia. Cancer Research. 79(13_Supplement). 1541–1541. 1 indexed citations

Greene, J.T., Rajeswaran Mani, Frank Frissora, et al.. (2019). Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling. Blood Advances. 3(8). 1255–1266. 2 indexed citations

Hu, Eileen, Priscilla Do, Rajeswaran Mani, et al.. (2017). Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma. Blood. 130. 3017–3017. 1 indexed citations

Chiang, Chi‐Ling, Rajeswaran Mani, Frank Frissora, et al.. (2017). Tumor Antigen ROR1 Targeted Delivery of MiR-29b in Chronic Lymphocytic Leukemia Induces Epigenetic Reprograming Resulting in Cell Cycle Arrest. Blood. 130. 4981–4981. 2 indexed citations

Mani, Rajeswaran, Chi‐Ling Chiang, Frank Frissora, et al.. (2016). CD33 Targeted Immunoliposomal Delivery of OSU-2S, a Non-Immunosuppressive FTY720 Derivative, Mediates Selective Cytotoxicity in Acute Myeloid Leukemia. Blood. 128(22). 2748–2748. 1 indexed citations

Mani, Rajeswaran, Chi‐Ling Chiang, Frank Frissora, et al.. (2015). ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo. Experimental Hematology. 43(9). 770–774.e2. 18 indexed citations

Beckwith, Kyle A., Frank Frissora, Matthew Stefanovski, et al.. (2014). The CD37-targeted antibody–drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model. Leukemia. 28(7). 1501–1510. 29 indexed citations

Motiwala, Tasneem, Nicola Zanesi, Frank Frissora, et al.. (2014). PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model. Leukemia. 29(6). 1350–1359. 13 indexed citations

10.

Mani, Rajeswaran, Yicheng Mao, Frank Frissora, et al.. (2013). Tumor Antigen ROR1 Targeted Delivery Of FTY720 Derivative OSU-2S Prolongs Survival In ROR1 Engineered Mouse Model Of Chronic Lymphocytic Leukemia. Blood. 122(21). 4168–4168. 1 indexed citations

11.

Raghunandan, Rama, Frank Frissora, & Natarajan Muthusamy. (2012). Modulation of Ets‐1 Expression in B Lymphocytes is Dependent on the Antigen Receptor–mediated Activation Signals and Cell Cycle Status. Scandinavian Journal of Immunology. 77(2). 75–83. 4 indexed citations

12.

Bai, Li‐Yuan, Yihui Ma, Samuel K. Kulp, et al.. (2011). OSU‐DY7, a novel D‐tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen‐activated protein kinase pathway. British Journal of Haematology. 153(5). 623–633. 6 indexed citations

13.

Muthusamy, Natarajan, et al.. (2011). Recombination activation gene-2-deficient blastocyst complementation analysis reveals an essential role for nuclear factor I-A transcription factor in T-cell activation. International Immunology. 23(6). 385–390. 2 indexed citations

14.

Liu, Qing, Xiaobin Zhao, Frank Frissora, et al.. (2007). FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood. 111(1). 275–284. 127 indexed citations

15.

Chen, Hui‐Chen, Frank Frissora, Joan E. Durbin, & Natarajan Muthusamy. (2003). Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells. Cellular Immunology. 225(1). 42–52. 18 indexed citations

16.

Frissora, Frank, Hui‐Chen Chen, Joan E. Durbin, Subbarao Bondada, & Natarajan Muthusamy. (2003). IFN‐γ‐mediated inhibition of antigen receptor‐induced B cell proliferation and CREB‐1 binding activity requires STAT‐1 transcription factor. European Journal of Immunology. 33(4). 907–912. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact